Haemonetics Total Assets 2012-2025 | HAE
Haemonetics total assets from 2012 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
|
Haemonetics Annual Total Assets (Millions of US $) |
|
|---|---|
| 2025 | $2,451 |
| 2024 | $2,196 |
| 2023 | $1,935 |
| 2022 | $1,860 |
| 2021 | $1,820 |
| 2020 | $1,267 |
| 2019 | $1,275 |
| 2018 | $1,237 |
| 2017 | $1,239 |
| 2016 | $1,319 |
| 2015 | $1,485 |
| 2014 | $1,514 |
| 2013 | $1,462 |
| 2012 | $911 |
| 2011 | $833 |
|
Haemonetics Quarterly Total Assets (Millions of US $) |
|
|---|---|
| 2025-09-30 | $2,442 |
| 2025-06-30 | $2,462 |
| 2025-03-31 | $2,451 |
| 2024-12-31 | $2,531 |
| 2024-09-30 | $2,525 |
| 2024-06-30 | $2,541 |
| 2024-03-31 | $2,196 |
| 2023-12-31 | $2,200 |
| 2023-09-30 | $2,011 |
| 2023-06-30 | $1,962 |
| 2023-03-31 | $1,935 |
| 2022-12-31 | $1,878 |
| 2022-09-30 | $1,865 |
| 2022-06-30 | $1,821 |
| 2022-03-31 | $1,860 |
| 2021-12-31 | $1,831 |
| 2021-09-30 | $1,801 |
| 2021-06-30 | $1,794 |
| 2021-03-31 | $1,820 |
| 2020-12-31 | $1,318 |
| 2020-09-30 | $1,418 |
| 2020-06-30 | $1,433 |
| 2020-03-31 | $1,267 |
| 2019-12-31 | $1,238 |
| 2019-09-30 | $1,191 |
| 2019-06-30 | $1,260 |
| 2019-03-31 | $1,275 |
| 2018-12-31 | $1,228 |
| 2018-09-30 | $1,266 |
| 2018-06-30 | $1,241 |
| 2018-03-31 | $1,237 |
| 2017-12-31 | $1,312 |
| 2017-09-30 | $1,271 |
| 2017-06-30 | $1,251 |
| 2017-03-31 | $1,239 |
| 2016-12-31 | $1,306 |
| 2016-09-30 | $1,335 |
| 2016-06-30 | $1,317 |
| 2016-03-31 | $1,319 |
| 2015-12-31 | $1,336 |
| 2015-09-30 | $1,419 |
| 2015-06-30 | $1,427 |
| 2015-03-31 | $1,485 |
| 2014-12-31 | $1,474 |
| 2014-09-30 | $1,475 |
| 2014-06-30 | $1,477 |
| 2014-03-31 | $1,514 |
| 2013-12-31 | $1,488 |
| 2013-09-30 | $1,484 |
| 2013-06-30 | $1,480 |
| 2013-03-31 | $1,462 |
| 2012-12-31 | $1,474 |
| 2012-09-30 | $1,455 |
| 2012-06-30 | $928 |
| 2012-03-31 | $911 |
| 2011-12-31 | $848 |
| 2011-09-30 | $824 |
| 2011-06-30 | $853 |
| 2011-03-31 | $833 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.378B | $1.361B |
| Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood supply chain, helping better clinical outcomes. It acquired Pall Corporation's blood collection, filtration and processing product lines. It entered into a long-term supply agreement with Pall. The company acquired Hemerus Medical. It operates under 3 segments: Plasma, Blood Center, and Hospital. Plasma includes plasma collection devices and disposables, plasma donor management software, anticoagulant and saline sold to plasma customers. Blood Center includes blood collection and processing devices and disposables for red cells, platelets and whole blood as well as related donor management software. Hospital includes three product lines, namely, Hemostasis Management, Cell Salvage and Transfusion Management. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $211.725B | 24.40 |
| EssilorLuxottica (ESLOY) | France | $146.103B | 0.00 |
| Stryker (SYK) | United States | $139.118B | 27.62 |
| Boston Scientific (BSX) | United States | $130.559B | 29.85 |
| Medtronic (MDT) | Ireland | $124.048B | 17.19 |
| Medline (MDLN) | United States | $57.961B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.907B | 0.00 |
| Agilent Technologies (A) | United States | $39.588B | 25.03 |
| ResMed (RMD) | United States | $37.591B | 26.02 |
| GE HealthCare Technologies (GEHC) | United States | $37.239B | 17.81 |
| Koninklijke Philips (PHG) | Netherlands | $28.483B | 18.60 |
| Terumo (TRUMY) | Japan | $20.476B | 23.05 |
| Insulet (PODD) | United States | $20.239B | 62.82 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.303B | 10.79 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.893B | 0.00 |
| Baxter (BAX) | United States | $10.338B | 8.34 |
| Sunny Optical Technology (SNPTF) | China | $9.589B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.457B | 30.41 |
| Demant (WILYY) | Denmark | $7.372B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.261B | 12.98 |
| Envista Holdings (NVST) | United States | $4.150B | 23.81 |
| BillionToOne (BLLN) | United States | $4.061B | 0.00 |
| ICU Medical (ICUI) | United States | $3.855B | 24.48 |
| Prestige Consumer Healthcare (PBH) | United States | $3.131B | 14.28 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.099B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.255B | 14.50 |
| Perrigo (PRGO) | Ireland | $2.068B | 5.18 |
| Neogen (NEOG) | United States | $2.012B | 44.05 |
| LeMaitre Vascular (LMAT) | United States | $2.002B | 40.31 |
| AtriCure (ATRC) | United States | $1.942B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.805B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.678B | 73.55 |
| Phibro Animal Health (PAHC) | United States | $1.665B | 16.63 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.471B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.437B | 20.80 |
| Kestra Medical Technologies (KMTS) | United States | $1.333B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.176B | 348.86 |
| Capricor Therapeutics (CAPR) | United States | $1.113B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.062B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.002B | 0.00 |
| InMode (INMD) | Israel | $0.881B | 9.96 |
| Valneva SE (VALN) | France | $0.867B | 0.00 |
| Omeros (OMER) | United States | $0.852B | 0.00 |
| CeriBell (CBLL) | United States | $0.814B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.578B | 15.67 |
| Cerus (CERS) | United States | $0.499B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.479B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.458B | 0.00 |
| Brainsway (BWAY) | Israel | $0.454B | 77.27 |
| Canopy Growth (CGC) | Canada | $0.438B | 0.00 |
| Quanterix (QTRX) | United States | $0.346B | 0.00 |
| Evolus (EOLS) | United States | $0.337B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.279B | 22.21 |
| TriSalus Life Sciences (TLSI) | United States | $0.276B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.240B | 141.00 |
| TerrAscend (TSNDF) | Canada | $0.239B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.232B | 0.00 |
| High Tide (HITI) | Canada | $0.224B | 0.00 |
| Organigram Global (OGI) | Canada | $0.218B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Sanara MedTech (SMTI) | United States | $0.203B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.196B | 17.27 |
| Accendra Health (ACH) | United States | $0.195B | 1.95 |
| OraSure Technologies (OSUR) | United States | $0.193B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.192B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.158B | 0.00 |
| Apyx Medical (APYX) | United States | $0.153B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.149B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.146B | 0.00 |
| Fonar (FONR) | United States | $0.116B | 16.79 |
| Jushi Holdings (JUSHF) | United States | $0.114B | 0.00 |
| MacroGenics (MGNX) | United States | $0.109B | 0.00 |
| Exagen (XGN) | United States | $0.106B | 0.00 |
| Biote (BTMD) | United States | $0.106B | 4.64 |
| Sharps Technology (STSS) | United States | $0.069B | 0.00 |
| ImmuCell (ICCC) | United States | $0.058B | 24.46 |
| Nephros (NEPH) | United States | $0.048B | 34.46 |
| Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
| Veru (VERU) | United States | $0.043B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.038B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.031B | 15.67 |
| Jin Medical (ZJYL) | China | $0.024B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.023B | 0.00 |
| Bonk (BNKK) | United States | $0.018B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.007B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |